Dashboard
Curated content
Startups & Scaleups
Job openings
Corporates
Investors
Funding rounds
Exits
People
More
Investment heatmap
Themes
Ecosystems
Matching tool
Blog
Reports
All Companies
Imago BioSciences
Save
Imago BioSciences
Verified
We are a company dedicated to translating state-of-the art science into novel medicines for the treatment of diseases
San Carlos United States (HQ)
http://imagobio.com
https://twitter.com/imagobiorx
https://www.linkedin.com/company/imago-biosciences-inc.
B2B
health
biotechnology
biotechnology
medical
Edit
Company information
Edit
Launch date
2012
Employees
2
people
Ownership
venture capital
Firm valuation
€291—436m
(Dealroom.co estimates Nov 2020.)
Imago BioSciences funding
Imago BioSciences investors
Edit
Date
Investors
Amount
Round
Oct 2014
Clarus Ventures
Amgen Ventures
Frazier Healthcare Partners
$26.5m
SERIES A
Mar 2019
Greenspring Associates
Amgen Ventures
Omega Funds
Frazier Healthcare Partners
Highlight Capital
$40m
SERIES B
Nov 2020
Blackstone
Farallon Capital Management
BlackRock
Pharmaron Holding
Greenspring Associates
Amgen Ventures
Omega Funds
Frazier Healthcare Partners
Xeraya Capital
MRL Ventures
Irving Investors
Kingdon Capital
Highlight Capital
T. Rowe Price
Citadel
$80m
SERIES C
Total Funding
€133m
Recent News about Imago BioSciences
Edit
Tech stack
apache
bootstrap
google analytics
google font api
mysql
php
slick
twitter emoji (twemoji)
twitter bootstrap
wordpress
yoast seo
jquery
Imago BioSciences team
Are you an employee or an investor of this company?
Add your profile
